Pierre Fabre  

  • Booth: 30167

Pierre Fabre is a French pharmaceutical and dermo-cosmetic company operating in more than 130 countries. 35-year experience in innovation, development, manufacturing & commercialization has brought its international recognition in oncology. The company has recently reaffirmed oncology as one of its top R&D and commercial priorities, focusing on targeted therapies, biotherapies & immuno-oncology. Its therapeutic areas cover high unmet medical needs, including hemato-oncology & dermato-oncology. Pierre Fabre is owned by a government-recognized public-interest foundation, Fondation Pierre Fabre.


 Products

  • Pierre Fabre Laboratories
    Pierre Fabre Laboratories is a leading French medical and beauty care company with 4 decades of experience in innovation, development, manufacturing, and commercialization in oncology. The company dedicated about 80% of its R&D spendings to oncology in 2022 with a focus on targeted therapies. Its current commercial portfolio in oncology covers colorectal, breast and lung cancers, melanoma, hematology, and pre-cancerous skin conditions.
     ...

  • Pierre Fabre Laboratories
    Pierre Fabre Laboratories is a leading French medical and beauty care company with 4 decades of experience in innovation, development, manufacturing, and commercialization in oncology. The company dedicated about 80% of its R&D spendings to oncology in 2022 with a focus on targeted therapies. Its current commercial portfolio in oncology covers colorectal, breast and lung cancers, melanoma, hematology, and pre-cancerous skin conditions.
     ...